General Information of the Compound
| Compound ID |
CP0402124
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
ethyl 3-[4-[(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-11,15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]anilino]propanoate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H44N2O5
|
||||||||||||||||||
| Molecular Weight |
572.746
|
||||||||||||||||||
| Canonical SMILES |
CCOC(=O)CCNc1ccc(cc1)[C@H]1C[C@]23CC[C@]1(OC)[C@@H]1Oc4c5c(C[C@H]2N(CC2CC2)CC[C@@]315)ccc4OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H44N2O5/c1-4-41-29(38)13-17-36-25-10-7-23(8-11-25)26-20-33-14-15-35(26,40-3)32-34(33)16-18-37(21-22-5-6-22)28(33)19-24-9-12-27(39-2)31(42-32)30(24)34/h7-12,22,26,28,32,36H,4-6,13-21H2,1-3H3/t26-,28-,32-,33-,34+,35-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MGNBQDNMQGAURK-ZUFGVENISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01526, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01549, Mu-type opioid receptor